Impact of COVID-19 on the prevalence of oral and maxillofacial disorders: A retrospective cohort study DOI Creative Commons
Bashar H. Abdullah, Omar Museedi, Noor Allawi

et al.

Science Progress, Journal Year: 2025, Volume and Issue: 108(1)

Published: Jan. 1, 2025

Objective The COVID-19 pandemic has impacted various health conditions. Emerging evidence suggests that may trigger or exacerbate oral and maxillofacial conditions, yet data from Iraq the broader Middle East remain limited. This retrospective cohort study, conducted at Laboratory of Oral Pathology, College Dentistry, University Baghdad, explores potential links between infection disorders. Methods was a study using Baghdad. Cases were divided into pre-COVID-19 post-COVID-19 periods. Chi-square tests assessed differences in pathologies incidence, while logistic regression analyzed associations with status corticosteroid use. Results Mucormycosis cases demonstrated significant increase 3 (pre-COVID-19) to 23 (post-COVID-19), 65.22% patients testing COVID-19-positive. A mucormycosis severity observed after (χ² = 14.24, p 0.0026). Logistic identified age (coefficient 0.8738) as having association severe mucormycosis, 0.1272) exerted lesser effect. Sjögren's syndrome increased 15 25 cases, model area under curve 0.8, indicating substantial ability distinguish symptom changes pre- vs. post-COVID-19. Conclusion findings suggest considerably incidence syndrome. Older positivity be key drivers whereas appeared symptoms. These results underscore importance vigilant monitoring targeted therapeutic strategies for managing conditions during viral pandemics.

Language: Английский

Acceptance or rejection of the COVID-19 Vaccine: A cross-sectional study among Orthodontists DOI Creative Commons
Giuseppe Minervini,

Zainab M Kadhom,

Alaa Faleh Albo Hassan

et al.

Journal of Contemporary Orthodontics, Journal Year: 2025, Volume and Issue: 9(1), P. 48 - 53

Published: Feb. 8, 2025

Close contact with the infected patient is one reason for spread of infection. COVID-19 can easily infect orthodontists; it may be found in saliva droplets during removal or insertion orthodontic fixed appliance components even removable appliance. This study aims to assess acceptance rejection vaccine among Iraqi orthodontists. A web-based cross-sectional survey orthodontists Iraq was conducted. Thirteen pre-structured questions were sent a Google Form via their WhatsApp and Telegram groups. There 123 participating this survey. The majority participants (96.75%) aware COVID-19, 62.60% suggested that coronavirus poses significant risk. Orthodontists who took accounted 93.50%; them, those preferred Pfizer 57.39%. side effects associated leading reasons refusal. Although there high level awareness about viruses orthodontists, some abstained from because fear. vaccines number got achieve precise infection control clinics decrease viral spread.

Language: Английский

Citations

0
Impact of COVID-19 on the prevalence of oral and maxillofacial disorders: A retrospective cohort study DOI Creative Commons
Bashar H. Abdullah, Omar Museedi, Noor Allawi

et al.

Science Progress, Journal Year: 2025, Volume and Issue: 108(1)

Published: Jan. 1, 2025

Objective The COVID-19 pandemic has impacted various health conditions. Emerging evidence suggests that may trigger or exacerbate oral and maxillofacial conditions, yet data from Iraq the broader Middle East remain limited. This retrospective cohort study, conducted at Laboratory of Oral Pathology, College Dentistry, University Baghdad, explores potential links between infection disorders. Methods was a study using Baghdad. Cases were divided into pre-COVID-19 post-COVID-19 periods. Chi-square tests assessed differences in pathologies incidence, while logistic regression analyzed associations with status corticosteroid use. Results Mucormycosis cases demonstrated significant increase 3 (pre-COVID-19) to 23 (post-COVID-19), 65.22% patients testing COVID-19-positive. A mucormycosis severity observed after (χ² = 14.24, p 0.0026). Logistic identified age (coefficient 0.8738) as having association severe mucormycosis, 0.1272) exerted lesser effect. Sjögren's syndrome increased 15 25 cases, model area under curve 0.8, indicating substantial ability distinguish symptom changes pre- vs. post-COVID-19. Conclusion findings suggest considerably incidence syndrome. Older positivity be key drivers whereas appeared symptoms. These results underscore importance vigilant monitoring targeted therapeutic strategies for managing conditions during viral pandemics.

Language: Английский

Citations

0